AmBisome (Astellas Pharma US, Inc.)


Welcome to the PulseAid listing for the AmBisome drug offered from Astellas Pharma US, Inc.. This Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Astellas Pharma US, Inc.
NON-PROPRIETARY NAME: amphotericin B
SUBSTANCE NAME: AMPHOTERICIN B
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-08-11
END MARKETING DATE: 0000-00-00


AmBisome HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAmBisome from Astellas Pharma US, Inc.
LABELER NAME: Astellas Pharma US, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/12.5mL)
START MARKETING DATE: 1997-08-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0469-3051_3ab7fe3b-149e-4ff5-826a-1e23a6d39b55
PRODUCT NDC: 0469-3051
APPLICATION NUMBER: NDA050740

Other AMPHOTERICIN B Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Astellas Pharma US, Inc.AmBisome
X-GEN Pharmaceuticals, Inc.Amphotericin B